Sab Biotherapeutics Stock Performance

SAB Biotherapeutics Relative Risk vs. Return Landscape

If you would invest  310.00  in SAB Biotherapeutics on November 13, 2025 and sell it today you would earn a total of  108.00  from holding SAB Biotherapeutics or generate 34.84% return on investment over 90 days. SAB Biotherapeutics is currently generating 0.5707% in daily expected returns and assumes 3.8247% risk (volatility on return distribution) over the 90 days horizon. In different words, 34% of stocks are less volatile than SAB, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days SAB Biotherapeutics is expected to generate 4.92 times more return on investment than the market. However, the company is 4.92 times more volatile than its market benchmark. It trades about 0.15 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

SAB Biotherapeutics Target Price Odds to finish over Current Price

Given the investment horizon of 90 days SAB Biotherapeutics has a beta of -0.28. This usually implies as returns on the benchmark increase, returns on holding SAB Biotherapeutics are expected to decrease at a much lower rate. During a bear market, however, SAB Biotherapeutics is likely to outperform the market. Additionally SAB Biotherapeutics has an alpha of 0.503, implying that it can generate a 0.5 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for SAB Biotherapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as SAB Biotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.18 4.16 8.14 Details

Intrinsic Valuation Low Real High 1.28 5.26 9.24 Details

5 Analysts Consensus Low Target High 8.53 9.38 10.41 Details

Earnings Estimates (0) Low Projected EPS High -0.25 -0.25 -0.25 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as SAB Biotherapeutics. Your research has to be compared to or analyzed against SAB Biotherapeutics' peers to derive any actionable benefits. When done correctly, SAB Biotherapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in SAB Biotherapeutics.

SAB Biotherapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. SAB Biotherapeutics is not an exception. The market had few large corrections towards the SAB Biotherapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold SAB Biotherapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of SAB Biotherapeutics within the framework of very fundamental risk indicators.

SAB Biotherapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of SAB Biotherapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for SAB Biotherapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

SAB Biotherapeutics Price Density Drivers

SAB Biotherapeutics Fundamentals Growth

When running SAB Biotherapeutics' price analysis, check to measure SAB Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SAB Biotherapeutics is operating at the current time. Most of SAB Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of SAB Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SAB Biotherapeutics' price. Additionally, you may evaluate how the addition of SAB Biotherapeutics to your portfolios can decrease your overall portfolio volatility.